KKR Health Care Strategic Growth Fund II
Managed by KKR
Overview
KKR Health Care Strategic Growth Fund II is the successor to KKR’s dedicated health care growth strategy. It focuses on growth-equity opportunities primarily in North America and Europe, including biopharmaceuticals, medical devices, health care services, life science tools and diagnostics, and health care information technology. The fund targets health care companies with established products or services that are pursuing commercialization and scale.
KKR is a global investment firm founded in 1976. Its private equity platform invests across buyout, core and growth strategies and combines local investment teams with sector specialists and broader operating, capital-markets and industry resources. Within health care, KKR’s strategic growth platform invests in growth-oriented businesses across the health care ecosystem, drawing on dedicated health care investment professionals in North America and Europe.
Selected investments
- Precipart — A precision-components manufacturer serving medical device and other specialized end markets.
- SunFire — A software and services provider supporting Medicare plan quoting, enrollment and post-enrollment engagement.
- Cortex — A medical technology company developing a platform for evaluating and treating atrial fibrillation.
- SkinSpirit — A provider of medical aesthetic services.
- Immedica — A pharmaceutical company focused on commercializing medicines for rare diseases.
- Brightline — A provider of virtual behavioral health care for children, adolescents and families.
Acquire an interest in KKR Health Care Strategic Growth Fund II
You might be able to acquire a position in KKR Health Care Strategic Growth Fund II. Sign up to explore available positions.
Gauge buyer interest for KKR Health Care Strategic Growth Fund II
Sign up here to anonymously gauge interest in your KKR Health Care Strategic Growth Fund II position.
Do you manage this fund? Get in touch to edit the text here.